Theodore Tsai

Summary

Affiliation: Novartis Institutes for BioMedical Research

Publications

  1. ncbi Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009
    T F Tsai
    Novartis Vaccines and Diagnostics, Cambridge, Massachusetts, United States
    Euro Surveill 15:. 2010
  2. doi Exposure to MF59-adjuvanted influenza vaccines during pregnancy--a retrospective analysis
    Theodore Tsai
    Novartis Vaccines and Diagnostics, Cambridge, MA 02139, USA
    Vaccine 28:1877-80. 2010
  3. doi Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy
    Theodore F Tsai
    Novartis Vaccines and Diagnostics Inc, 350 Massachusetts Avenue, Cambridge, MA 02139, USA
    Scand J Infect Dis 43:702-6. 2011
  4. ncbi MF59 adjuvanted seasonal and pandemic influenza vaccines
    Theodore F Tsai
    Novartis Vaccines, Cambridge, Massachusetts 02116, USA
    Yakugaku Zasshi 131:1733-41. 2011
  5. doi MF59 adjuvant: the best insurance against influenza strain diversity
    Derek T O'Hagan
    Novartis Vaccines and Diagnostics, Cambridge, MA, USA
    Expert Rev Vaccines 10:447-62. 2011

Detail Information

Publications6

  1. ncbi Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009
    T F Tsai
    Novartis Vaccines and Diagnostics, Cambridge, Massachusetts, United States
    Euro Surveill 15:. 2010
    ..Nevertheless, in all locations, the majority of the population remained susceptible to the pandemic virus at the beginning of the influenza season in the northern hemisphere, justifying the implementation of public health interventions...
  2. doi Exposure to MF59-adjuvanted influenza vaccines during pregnancy--a retrospective analysis
    Theodore Tsai
    Novartis Vaccines and Diagnostics, Cambridge, MA 02139, USA
    Vaccine 28:1877-80. 2010
    ..Further data will be forthcoming from planned post-licensure studies of adjuvanted H1N1 vaccines as they are distributed in the pandemic response...
  3. doi Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy
    Theodore F Tsai
    Novartis Vaccines and Diagnostics Inc, 350 Massachusetts Avenue, Cambridge, MA 02139, USA
    Scand J Infect Dis 43:702-6. 2011
    ....
  4. ncbi MF59 adjuvanted seasonal and pandemic influenza vaccines
    Theodore F Tsai
    Novartis Vaccines, Cambridge, Massachusetts 02116, USA
    Yakugaku Zasshi 131:1733-41. 2011
    ....
  5. doi MF59 adjuvant: the best insurance against influenza strain diversity
    Derek T O'Hagan
    Novartis Vaccines and Diagnostics, Cambridge, MA, USA
    Expert Rev Vaccines 10:447-62. 2011
    ....